Premium
Lexaria Bioscience Corporation (LEXXW)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Août 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -109.075 | -249.442 | -160.556 | -153.88 | -50.04 | -68.9 | -122.103 | -96.988 |
| Return on Equity (%) | -130.882 | -255.974 | -168.061 | -170.314 | -51.808 | -70.245 | -129.267 | -112.119 |
| Return on Invested Capital (%) | -128.232 | -255.974 | -169.455 | -56.973 | -74.328 | -71.844 | -128.386 | -114.678 |
| Operating Margin (%) | -3004.688 | -1526.328 | -1872.973 | -1063.542 | -576.584 | -2895.294 | -2970.354 | -1251.94 |
| Net Profit Margin (%) | -2920.313 | -1524.018 | -1846.396 | -1102.604 | -554.683 | -2850.588 | -2949.115 | -1249.138 |
| Book Value Per Share | 0.046 | 0.03 | 0.028 | 0.024 | 2.218 | 1.201 | 0.274 | 0.452 |
| Earnings Per Share | -0.032 | -0.087 | -0.052 | -0.047 | -0.703 | -1.222 | -0.824 | -0.367 |
| Cash Per Share | 0.043 | 0.023 | 0.016 | 0.014 | 1.907 | 0.977 | 0.167 | 0.411 |
| Working Capital Per Share | 0.046 | 0.03 | 0.021 | 0.019 | 2.146 | 1.14 | 0.239 | 0.43 |
| Operating Profit Per Share | 0.001 | 0.005 | 0.003 | 0.003 | 0.116 | 0.031 | 0.024 | 0.029 |
| EBIT Per Share | -0.033 | -0.087 | -0.053 | -0.045 | -0.731 | -1.241 | -0.83 | -0.367 |
| EBITDA Per Share | -0.033 | -0.087 | -0.053 | -0.045 | -0.731 | -1.241 | -0.83 | -0.367 |
| Free Cash Flow Per Share | -0.032 | -0.086 | -0.043 | -0.048 | -0.709 | -1.191 | -0.826 | -0.362 |
| Fin d'année 31 Août 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fin d'année 31 Août 2024 | Nov 2022 | Fév 2023 | Mai 2023 | Août 2023 | Nov 2023 | Fév 2024 | Mai 2024 | Août 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | -1751.485 | N/A | N/A | N/A | -784.768 | N/A | N/A | N/A |
| Net Profit Margin (%) | -1738.614 | N/A | N/A | N/A | -780.795 | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 0 |
| Ratio cours/bénéfice | 0 |
| Ratio prix/ventes | 0 |
| Ratio prix/liquidités | 0 |
| Ratio prix/valeur comptable | 0 |
| Rendement de dividende | - |
| Actions en circulation | 0 |
| Volume moyen (1 semaine) | 0 |
| Volume moyen (1 mois) | 0 |
| Variation sur 52 semaines | - |
| Plus haut sur 52 semaines | - |
| Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
